MORF vs. LABU
Compare and contrast key facts about Morphic Holding, Inc. (MORF) and Direxion Daily S&P Biotech Bull 3x Shares (LABU).
LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015.
Performance
MORF vs. LABU - Performance Comparison
Loading graphics...
MORF vs. LABU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MORF Morphic Holding, Inc. | 0.00% | 0.00% | 97.33% | 7.96% | -43.54% | 41.22% | 95.51% | -4.67% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 4.20% | 79.17% | -26.02% | -13.41% | -80.36% | -64.15% | 74.66% | 21.38% |
Returns By Period
MORF
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LABU
- 1D
- 22.31%
- 1M
- -3.83%
- YTD
- 4.20%
- 6M
- 78.34%
- 1Y
- 175.22%
- 3Y*
- 19.86%
- 5Y*
- -36.38%
- 10Y*
- -11.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MORF vs. LABU — Risk / Return Rank
MORF
LABU
MORF vs. LABU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Morphic Holding, Inc. (MORF) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| MORF | LABU | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.04 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.38 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.12 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.24 | — |
Correlation
The correlation between MORF and LABU is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
MORF vs. LABU - Dividend Comparison
MORF has not paid dividends to shareholders, while LABU's dividend yield for the trailing twelve months is around 0.74%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MORF Morphic Holding, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.74% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Drawdowns
MORF vs. LABU - Drawdown Comparison
Loading graphics...
Drawdown Indicators
| MORF | LABU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -99.18% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -36.66% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -97.75% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.96% | — |
Current DrawdownCurrent decline from peak | — | -96.33% | — |
Average DrawdownAverage peak-to-trough decline | — | -81.45% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 12.01% | — |
Volatility
MORF vs. LABU - Volatility Comparison
Loading graphics...
Volatility by Period
| MORF | LABU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 33.99% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 56.88% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 87.36% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 95.74% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 95.91% | — |